Regulatory Shift Paves Way for AI-Driven Heart Disease Diagnosis
Now, with the ability to measure coronary inflammation through AI-enhanced CT scans and to more accurately determine a person's risk of heart attack, we can intervene earlier and more effectively.
The Critical Link: How Supporting Nurse Managers Can Help Nurses — And Improve Healthcare
By supporting managers, healthcare organizations can make the workplace better for nurses. That could not only improve retention but build a pipeline of nurse managers.
First Therapy for Rare Tumor Is a Blockbuster Prospect, But Does Precigen Have the Cash to Make It Happen?
Precigen’s Papzimeos is the first FDA-approved drug for the rare disease recurrent respiratory papillomatosis, or RRP. While this immunotherapy carries blockbuster expectations, Precigen’s financial reports indicate budgetary challenges.
Insurers are Pulling Back on MA. How Does this Affect Patients?
Many insurers seem to be retreating from Medicare Advantage by exiting unprofitable markets and reducing benefits. This could be extremely disruptive to patients, experts warn.
AI Meets Care Transitions: How One Startup Is Seeking to Reduce Readmissions and Costs
Boston-based startup Cascala Health raised an $8.6 million seed round to expand its AI platform for risk-bearing providers. The platform is designed to make patient care transitions safer and more efficient, as well as to help care teams spot risks earlier.